Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
210.01
+3.36 (1.63%)
At close: Nov 26, 2025, 4:00 PM EST
212.50
+2.49 (1.19%)
After-hours: Nov 26, 2025, 7:09 PM EST
Ascendis Pharma Market Cap
Ascendis Pharma has a market cap or net worth of $12.83 billion as of November 26, 2025. Its market cap has increased by 74.26% in one year.
Market Cap
12.83B
Enterprise Value
13.15B
1-Year Change
74.26%
Ranking
Category
Stock Price
$210.01
Market Cap Chart
Since January 28, 2015, Ascendis Pharma's market cap has increased from $448.80M to $12.83B, an increase of 2,759.01%. That is a compound annual growth rate of 36.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 12.83B | 61.99% |
| Dec 31, 2024 | 7.92B | 9.08% |
| Dec 29, 2023 | 7.26B | 4.27% |
| Dec 30, 2022 | 6.96B | -3.83% |
| Dec 31, 2021 | 7.24B | -17.63% |
| Dec 31, 2020 | 8.79B | 32.38% |
| Dec 31, 2019 | 6.64B | 152.21% |
| Dec 31, 2018 | 2.63B | 80.76% |
| Dec 29, 2017 | 1.46B | 185.54% |
| Dec 30, 2016 | 510.20M | 10.84% |
| Dec 31, 2015 | 460.30M | 2.56% |
| Jan 28, 2015 | 448.80M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 993.82B |
| Johnson & Johnson | 497.93B |
| AbbVie | 409.68B |
| UnitedHealth Group | 295.56B |
| AstraZeneca | 288.24B |
| Merck & Co. | 262.25B |
| Novartis AG | 248.38B |
| Thermo Fisher Scientific | 224.59B |